| First Author | Lin FH | Year | 2020 |
| Journal | Exp Cell Res | Volume | 396 |
| Issue | 2 | Pages | 112297 |
| PubMed ID | 32980291 | Mgi Jnum | J:301212 |
| Mgi Id | MGI:6503236 | Doi | 10.1016/j.yexcr.2020.112297 |
| Citation | Lin FH, et al. (2020) Lmod3 promotes myoblast differentiation and proliferation via the AKT and ERK pathways. Exp Cell Res 396(2):112297 |
| abstractText | Mutations in the Lmod3 gene have been identified as a genetic cause of nemaline myopathy. However, the mechanism underlying this disease and the function of Lmod3 remain largely unknown. In this study, we found that Lmod3 knockdown in C2C12 cells impaired myoblast differentiation, whereas enforced Lmod3 expression enhanced such differentiation. We also discovered that myoblast proliferation was promoted by Lmod3 overexpression but impeded by its knockdown. Additionally, knockdown of Lmod3 led to apoptosis in myoblasts. Concurrently, forced Lmod3 expression in C2C12 cells contributed to activation of the AKT and ERK pathways during myoblast differentiation and proliferation, respectively. Conversely, knockdown of Lmod3 in C2C12 cells produced the opposite results. Furthermore, administration of IGF-1, a booster of both AKT and ERK pathways, partially rescued the inhibitory effect of Lmod3 knockdown on both differentiation and proliferation of C2C12 cells. These results suggest that Lmod3 promotes differentiation and proliferation of myoblasts through the AKT and ERK pathways, respectively. |
